{"id":"https://openalex.org/W2107657398","doi":"https://doi.org/10.1200/jco.2003.12.144","title":"Immunization With Melan-A Peptide-Pulsed Peripheral Blood Mononuclear Cells Plus Recombinant Human Interleukin-12 Induces Clinical Activity and T-Cell Responses in Advanced Melanoma","display_name":"Immunization With Melan-A Peptide-Pulsed Peripheral Blood Mononuclear Cells Plus Recombinant Human Interleukin-12 Induces Clinical Activity and T-Cell Responses in Advanced Melanoma","alternate_titles":[],"publication_year":2003,"publication_date":"2003-06-12","ids":{"openalex":"https://openalex.org/W2107657398","doi":"https://doi.org/10.1200/jco.2003.12.144","mag":"2107657398","pmid":"https://pubmed.ncbi.nlm.nih.gov/12805336"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2003.12.144","doi":"https://doi.org/10.1200/jco.2003.12.144","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2003.12.144","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2107657398"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5037339262","display_name":"Amy Peterson","orcid":"https://orcid.org/0000-0001-8273-1365","observed_orcids":["https://orcid.org/0000-0001-8273-1365"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Amy C. Peterson","raw_affiliation_strings":["From the University of Chicago, Departments of Pathology and Medicine, Section of Hematology/Oncology, and the Ben May Institute for Cancer Research, Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the University of Chicago, Departments of Pathology and Medicine, Section of Hematology/Oncology, and the Ben May Institute for Cancer Research, Chicago, IL","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010577942","display_name":"Helena Harlin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Helena Harlin","raw_affiliation_strings":["From the University of Chicago, Departments of Pathology and Medicine, Section of Hematology/Oncology, and the Ben May Institute for Cancer Research, Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the University of Chicago, Departments of Pathology and Medicine, Section of Hematology/Oncology, and the Ben May Institute for Cancer Research, Chicago, IL","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5108071644","display_name":"Thomas F. Gajewski","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Thomas F. Gajewski","raw_affiliation_strings":["From the University of Chicago, Departments of Pathology and Medicine, Section of Hematology/Oncology, and the Ben May Institute for Cancer Research, Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the University of Chicago, Departments of Pathology and Medicine, Section of Hematology/Oncology, and the Ben May Institute for Cancer Research, Chicago, IL","institution_ids":["https://openalex.org/I40347166"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I40347166"],"apc_list":null,"apc_paid":null,"fwci":4.5672,"has_fulltext":false,"cited_by_count":167,"citation_normalized_percentile":{"value":0.95819626,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"21","issue":"12","first_page":"2342","last_page":"2348"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":0.00430000014603138,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.001500000013038516,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.703000009059906},{"id":"https://openalex.org/keywords/il-12","display_name":"IL-12","score":0.9089999794960022},{"id":"https://openalex.org/keywords/cancer-vaccines","display_name":"cancer vaccines","score":0.49799999594688416},{"id":"https://openalex.org/keywords/vaccine-adjuvants","display_name":"vaccine adjuvants","score":0.8259999752044678},{"id":"https://openalex.org/keywords/cd8-t-cell-responses","display_name":"CD8+ T cell responses","score":0.8920000195503235},{"id":"https://openalex.org/keywords/interferon-gamma","display_name":"interferon-gamma","score":0.8989999890327454},{"id":"https://openalex.org/keywords/hla-a2","display_name":"HLA-A2","score":0.8999999761581421},{"id":"https://openalex.org/keywords/tumor-antigens","display_name":"tumor antigens","score":0.382999986410141},{"id":"https://openalex.org/keywords/clinical-response","display_name":"clinical response","score":0.40700000524520874},{"id":"https://openalex.org/keywords/survival","display_name":"survival","score":0.3540000021457672},{"id":"https://openalex.org/keywords/metastatic-melanoma","display_name":"metastatic melanoma","score":0.6940000057220459}],"concepts":[{"id":"https://openalex.org/C2779053233","wikidata":"https://www.wikidata.org/wiki/Q731235","display_name":"ELISPOT","level":4,"score":0.9315311908721924},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8358736634254456},{"id":"https://openalex.org/C137061746","wikidata":"https://www.wikidata.org/wiki/Q736033","display_name":"Peripheral blood mononuclear cell","level":3,"score":0.6531980037689209},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5989943146705627},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.5517154932022095},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5189249515533447},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.5106588006019592},{"id":"https://openalex.org/C2777863537","wikidata":"https://www.wikidata.org/wiki/Q357896","display_name":"Adjuvant","level":2,"score":0.4764688014984131},{"id":"https://openalex.org/C2780801004","wikidata":"https://www.wikidata.org/wiki/Q1415366","display_name":"Immunization","level":3,"score":0.44431352615356445},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.4404960572719574},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.10870563983917236},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000951","descriptor_name":"Antigens, Neoplasm","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007371","descriptor_name":"Interferon-gamma","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007963","descriptor_name":"Leukocytes, Mononuclear","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009362","descriptor_name":"Neoplasm Metastasis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009363","descriptor_name":"Neoplasm Proteins","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D013601","descriptor_name":"T-Lymphocytes","qualifier_ui":"Q000166","qualifier_name":"cytology","is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015789","descriptor_name":"HLA-A2 Antigen","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018414","descriptor_name":"CD8-Positive T-Lymphocytes","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D018664","descriptor_name":"Interleukin-12","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D019496","descriptor_name":"Cancer Vaccines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020133","descriptor_name":"Reverse Transcriptase Polymerase Chain Reaction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058965","descriptor_name":"MART-1 Antigen","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1200/jco.2003.12.144","doi":"https://doi.org/10.1200/jco.2003.12.144","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2003.12.144","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},{"id":"pmid:12805336","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12805336","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology","raw_type":"Clinical Trial"},{"id":"mag:2306763867","doi":null,"is_oa":false,"landing_page_url":"https://www.psmrf.org/pdfs/Gajewski%20JCO.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":30,"referenced_works":["https://openalex.org/W1485703951","https://openalex.org/W1511686437","https://openalex.org/W1551774211","https://openalex.org/W1572267688","https://openalex.org/W1658565302","https://openalex.org/W1773775383","https://openalex.org/W1945740511","https://openalex.org/W1983806918","https://openalex.org/W2008954472","https://openalex.org/W2018227907","https://openalex.org/W2026763255","https://openalex.org/W2042295867","https://openalex.org/W2059153792","https://openalex.org/W2066964346","https://openalex.org/W2099515509","https://openalex.org/W2108221597","https://openalex.org/W2108473659","https://openalex.org/W2117216774","https://openalex.org/W2118704687","https://openalex.org/W2127871008","https://openalex.org/W2139158451","https://openalex.org/W2146600597","https://openalex.org/W2151707711","https://openalex.org/W2167008563","https://openalex.org/W2168992823","https://openalex.org/W2269774696","https://openalex.org/W2405695350","https://openalex.org/W2460790353","https://openalex.org/W3021254998","https://openalex.org/W4250451610"],"related_works":["https://openalex.org/W1511686437","https://openalex.org/W2164584613","https://openalex.org/W2005381406","https://openalex.org/W2062316082","https://openalex.org/W2045799644","https://openalex.org/W2004894025","https://openalex.org/W2000321549","https://openalex.org/W2122149354","https://openalex.org/W2269774696","https://openalex.org/W2140147891"],"abstract_inverted_index":{"PURPOSE:":[0],"Preclinical":[1],"studies":[2],"showed":[3],"that":[4,30,247],"immunization":[5,53,231],"with":[6,13,54,65,85,111,162],"peripheral":[7],"blood":[8],"mononuclear":[9],"cells":[10,194,223],"(PBMC)":[11],"loaded":[12],"tumor":[14,25],"antigen":[15],"peptides":[16],"plus":[17],"interleukin-12":[18],"(IL-12)":[19],"induced":[20],"CD8+":[21,178],"T-cell":[22,179],"responses":[23,92,180],"and":[24,74,99,102,108,121,140,155,224,241],"rejection.":[26],"We":[27],"recently":[28],"determined":[29],"recombinant":[31],"human":[32],"(rh)":[33],"IL-12":[34],"at":[35],"30":[36],"to":[37,243,251],"100":[38],"ng/kg":[39],"is":[40],"effective":[41],"as":[42],"a":[43,129,135,163,187,213,252],"vaccine":[44],"adjuvant":[45],"in":[46,62,190,221],"patients.":[47],"A":[48],"phase":[49],"II":[50],"study":[51],"of":[52,176,218],"Melan-A":[55,77,196],"peptide-pulsed":[56],"PBMC":[57],"+":[58],"rhIL-12":[59],"was":[60,80,149,156,212],"conducted":[61],"20":[63],"patients":[64,116,127,133,142,154],"advanced":[66],"melanoma.":[67],"PATIENTS":[68],"AND":[69],"METHODS:":[70],"Patients":[71],"were":[72,93,109,168],"HLA-A2-positive":[73],"had":[75,117,122,143],"documented":[76],"expression.":[78],"Immunization":[79],"performed":[81],"every":[82,88],"3":[83,171],"weeks":[84],"clinical":[86,112,225,245],"re-evaluation":[87],"three":[89,106],"cycles.":[90],"Immune":[91],"measured":[94],"by":[95,181],"ELISpot":[96,185],"assay":[97],"before":[98],"after":[100,199],"treatment":[101],"through":[103],"the":[104,216,219],"first":[105],"cycles,":[107],"correlated":[110,250],"outcome.":[113],"RESULTS:":[114],"Most":[115],"received":[118],"prior":[119],"therapy":[120],"visceral":[123],"metastases.":[124],"Nonetheless,":[125],"two":[126],"achieved":[128,134],"complete":[130],"response,":[131,139],"five":[132],"minor":[136],"or":[137,172],"mixed":[138],"four":[141],"stable":[144],"disease.":[145],"The":[146],"median":[147],"survival":[148],"12.25":[150],"months":[151],"for":[152,160],"all":[153],"not":[157,202],"yet":[158],"reached":[159],"those":[161],"normal":[164],"lactate":[165],"dehydrogenase.":[166],"There":[167,211],"no":[169],"grade":[170],"4":[173],"toxicities.":[174],"Measurement":[175],"specific":[177],"direct":[182],"ex":[183],"vivo":[184],"revealed":[186],"significant":[188],"increase":[189,220],"interferon":[191],"gamma-producing":[192],"T":[193],"against":[195,203],"(P":[197,209,227],"=.015)":[198],"vaccination,":[200],"but":[201],"an":[204],"Epstein-Barr":[205],"virus":[206],"control":[207],"peptide":[208],"=.86).":[210],"correlation":[214],"between":[215],"magnitude":[217],"Melan-A-specific":[222],"response":[226],"=.046).":[228],"CONCLUSION:":[229],"This":[230],"approach":[232],"may":[233],"be":[234,249],"more":[235],"straightforward":[236],"than":[237],"dendritic":[238],"cell":[239],"strategies":[240],"seems":[242],"have":[244],"activity":[246],"can":[248],"biologic":[253],"end":[254],"point.":[255]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2107657398","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":7},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":9},{"year":2014,"cited_by_count":9},{"year":2013,"cited_by_count":9},{"year":2012,"cited_by_count":9}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
